Tiova Rotacap
Tiova Rotacap Price range: $ 45,00 through $ 86,00
Back to products
Tizanidine
Tizanidine Price range: $ 88,00 through $ 214,00

Tizacare

Price range: $ 40,00 through $ 285,00

Tizacare is an effective muscle relaxant specifically designed to manage increased muscle tone and involuntary spasms. This medication is primarily indicated for individuals experiencing spasticity associated with chronic conditions like multiple sclerosis or spinal cord injuries. By temporarily calming nerve impulses in the spinal cord, it helps to effectively reduce stiffness and muscle tightness. Patients often find that Tizacare assists in improving overall physical mobility and comfort during daily activities. Its specialized formula works to provide targeted relief from the physical strain caused by persistent muscular tension.

Active substance: Tizanidine
SKU: Tizacare Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Tizacare belongs to a group of medicines called central alpha-2 adrenergic agonists. It acts primarily within the central nervous system to reduce muscle spasticity and excessive muscle tone.

In accordance with United States Food and Drug Administration (FDA) regulations, Tizacare is classified as a prescription-only medication. It must be dispensed exclusively upon receiving a valid order from a licensed healthcare provider, such as a physician practicing in Texas or any other US jurisdiction.

Property Details
Drug Name Tizacare
Active Ingredient Tizanidine hydrochloride
Therapeutic Class Central Alpha-2 Adrenergic Agonist / Muscle Relaxant
Dosage Form Oral tablet / capsule
Route of Administration Oral
Prescription Status Prescription only (Rx)
Primary Purpose Management of spasticity

Clinical Overview and Pharmacologic Profile

How the Drug Works

The active component of Tizacare, tizanidine, is a centrally acting alpha-2 adrenergic receptor agonist. It exerts its pharmacological action by stimulating presynaptic alpha-2 adrenergic receptors located in the spinal cord. This stimulation suppresses the presynaptic release of excitatory amino acids, specifically glutamate and aspartate, from spinal interneurons. By inhibiting these excitatory signals, Tizacare reduces polysynaptic reflex activity in the motor neurons of the spinal cord. Consequently, muscle spasms and involuntary muscle contractions are diminished while muscle strength is largely preserved for voluntary movement.

What Happens in the Body

Following oral administration, Tizacare is rapidly absorbed through the gastrointestinal tract, reaching peak plasma concentration within approximately 1 to 2 hours. The absolute oral bioavailability is around 40% due to extensive first-pass metabolism in the liver. Metabolism occurs predominantly via the cytochrome P450 enzyme system, specifically the CYP1A2 pathway. The elimination half-life of Tizacare ranges from approximately 2.5 to 4 hours. Renal excretion accounts for nearly 60% of metabolite elimination, while approximately 20% is cleared through fecal pathways. Hepatic impairment significantly increases plasma concentrations and systemic exposure.

Main Uses

Tizacare is FDA-approved for the management of spasticity associated with chronic neurological conditions. Its primary indications include reducing elevated muscle tone, spasms, and clonus secondary to multiple sclerosis or spinal cord injuries. By decreasing pathologically elevated muscle tone, it helps facilitate physical therapy, mobility, and daily activity management. Healthcare providers may occasionally prescribe Tizacare off-label for acute, painful musculoskeletal conditions or myofascial pain syndromes; however, these non-spastic uses represent off-label indications that lack formal FDA approval for long-term therapy and require careful clinical monitoring.

Dosing Schedule

Dosing of Tizacare must be highly individualized based on therapeutic response and patient tolerance. Initial treatment typically begins at a low dose of 2 mg to 4 mg taken orally, as a single dose. Because the therapeutic effect peaks within 1 to 2 hours and dissipates within 3 to 6 hours, administration may be repeated at 6- to 8-hour intervals if needed. The dose is gradually titrated upward by increments of 2 mg to 4 mg every 4 to 7 days. The maximum recommended single dose is 8 mg, and total daily intake should not exceed 36 mg within a 24-hour period. Dose adjustments are necessary for individuals with renal impairment (creatinine clearance below 25 mL/min).

Compatibility With Other Medicines

Tizacare exhibits critical drug interaction risks due to its metabolic reliance on the hepatic CYP1A2 enzyme. Co-administration with potent CYP1A2 inhibitors, such as fluvoxamine or ciprofloxacin, is strictly contraindicated because it dramatically elevates Tizacare exposure, leading to profound hypotension, extreme somnolence, and psychomotor impairment. Moderate CYP1A2 inhibitors (including oral contraceptives, zafirlukast, and fluoroquinolones like enoxacin) should be avoided or used with extreme caution. Combining Tizacare with antihypertensive agents increases the risk of severe blood pressure drops and bradycardia. Concurrent use of central nervous system depressants, including opioids, benzodiazepines, or sedating antihistamines, produces additive sedative effects.

Safety Guidelines and Patient Management

Adverse Reactions

Adverse reactions associated with Tizacare are often dose-dependent and commonly observed during the initiation and titration phases. Frequent side effects include dry mouth (xerostomia), somnolence, drowsiness, fatigue, weakness (asthenia), and dizziness. Gastrointestinal disturbances such as constipation, nausea, or abdominal discomfort may occur. Cardiovascular effects include a transient decrease in systolic and diastolic blood pressure, often accompanied by bradycardia. Less frequent but serious adverse effects include hepatotoxicity marked by elevated liver transaminases (ALT/AST), severe hypotension, syncope, and visual hallucinations. Abrupt withdrawal after chronic use can cause rebound hypertension, tachycardia, and hypertonia.

Important Precautions

Prior to initiating therapy, baseline liver function tests (ALT and AST) should be obtained and monitored periodically, particularly during the first six months of treatment. Tizacare should be used with extreme caution in patients with hepatic impairment, as drug clearance is significantly reduced. Renal impairment also alters pharmacokinetics, necessitating lower starting doses and vigilant monitoring for excessive sedation or hypotension. Geriatric patients may exhibit increased sensitivity to blood pressure drops and sedative effects, raising the risk of falls. Safety and efficacy in pediatric populations have not been established. Women who are pregnant or breastfeeding should consult a clinician, as safety data in these populations remain limited.

What to Avoid While Taking It

Patients taking Tizacare must avoid alcohol consumption entirely. Ethanol potentiates the central nervous system depressant effects of Tizacare, resulting in heightened sedation, impaired motor coordination, and an elevated risk of severe hypotension. Additionally, patients should maintain consistency regarding food intake. Taking Tizacare with food alters its peak concentration and overall absorption profile compared to taking it on an empty stomach; switching between fed and fasting states without medical consultation can lead to unpredictable therapeutic outcomes or unexpected side effects.

If You Skip a Dose

If a scheduled dose of Tizacare is missed, it should be taken as soon as remembered, provided the next scheduled dose is not imminent. If it is almost time for the subsequent dose, the missed dose should be skipped entirely, resuming the standard dosing schedule. Double doses should never be ingested to make up for a missed tablet, as doing so substantially increases the risk of acute toxicity, severe drowsiness, and dangerous drops in blood pressure.

Storage and Expiration

Tizacare should be stored at room temperature, ideally between 68°F and 77°F (20°C to 25°C), with brief excursions permitted between 59°F and 86°F (15°C to 30°C). Keep the container tightly closed and protected from excessive moisture, heat, and direct light. Store out of the reach of children and pets. Do not use the medication past the expiration date printed on the original packaging, and dispose of unused medication according to local environmental and pharmacy waste guidelines.

When to Get Emergency Care

Warning Sign Action Required
Severe dizziness, lightheadedness, or fainting (syncope) Seek immediate emergency medical evaluation.
Signs of liver dysfunction (yellowing of skin/eyes, dark urine, severe fatigue) Discontinue drug and contact a doctor immediately.
Hallucinations, confusion, or marked altered mental status Obtain urgent psychiatric/medical assessment.
Signs of severe allergic reaction (anaphylaxis, facial swelling, severe rash) Call emergency services (911) right away.
Unusually slow heart rate (bradycardia) combined with shortness of breath Seek prompt emergency medical care.

Common Questions

How long does the sedative effect of Tizacare typically last?

The peak sedative effect generally occurs within 1 to 2 hours following oral administration, corresponding to peak plasma levels. Drowsiness and cognitive impairment usually diminish after 3 to 6 hours as circulating levels decline. Because of these effects, patients should avoid driving or operating machinery until they understand how Tizacare affects them.

Can Tizacare tablets and capsules be used interchangeably?

While both formulations contain tizanidine, they display different absorption kinetics when taken with food. Food increases the peak concentration of tablets but delays and decreases the peak concentration of capsules. Patients should not switch between tablet and capsule formulations without explicit instructions and dose adjustment guidance from their prescriber.

Can Tizacare be stopped abruptly after prolonged daily use?

No. Abrupt cessation of Tizacare after chronic, high-dose administration can cause a withdrawal syndrome characterized by rebound hypertension, tachycardia, hypertonia, and anxiety. To discontinue therapy safely, healthcare providers typically implement a gradual dose-tapering schedule.

What should I do if I accidentally consume alcohol while taking Tizacare?

Accidental alcohol ingestion while on Tizacare significantly enhances CNS depression and hypotension. Patients experiencing severe drowsiness, dizziness, or confusion should avoid moving unassisted to prevent falls, and caregivers should contact emergency medical services if the patient becomes unresponsive or exhibits severe breathing difficulty.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

2mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία